Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-08

Clinical Trial Update: Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating sodium nitrite for safety and efficacy in sickle cell disease was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • sodium nitrite (sodium nitrite)

Snippet

Sponsor: Children's Hospital Los Angeles | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-02-08